The role of damage-associated molecular patterns in perioperative morbidities and mortalities of pediatric congenital heart diseases
The role of damage-associated molecular patterns in perioperative morbidities and mortalities of pediatric congenital heart diseases
批准号:
10669290
负责人:
Koichi Yuki
金额:
$22.13万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-01 至 2024-07-31
关键词:
AdultAgeBiologicalBiological AssayBirthBloodBlood PlateletsBlood TransfusionBody SizeBrainCardiac Surgery proceduresCardiopulmonary BypassCellsCessation of lifeChildChildhoodCirculationClinicalClinical ManagementCoagulation ProcessComplexDataDatabasesFailureFlow CytometryFunctional disorderGoalsHeartHeart ArrestHistonesHospital MortalityHumanImmuneImmunologicsIn VitroIncidenceIncubatedInfantInflammatoryInpatientsInterventionLigandsLive BirthLogisticsLungMediatingMedicalMitochondriaMolecularMorbidity - disease rateMusNeonatalNuclearOperative Surgical ProceduresOrganOutcomePathway interactionsPatientsPatternPattern RecognitionPattern recognition receptorPerfusionPerioperativePhysiologicalPlatelet ActivationPopulationPostoperative PeriodProductionRegional PerfusionReperfusion InjuryReporterReportingResearchRisk FactorsRodentRoleSepsisSignal PathwaySignal TransductionSourceStreamTLR2 geneTLR4 geneTestingTherapeutic InterventionThrombelastographyThrombophiliaThrombosisTimeToll-Like Receptor PathwayToll-like receptorsTraumaage groupage relatedcell injuryclinical carecongenital heart disordercytokineexperienceextracellularhigh riskhistological specimensimmune activationimprovedin vivomRNA sequencingmechanical circulatory supportmortalitymouse modelneonateneutrophilnovel therapeutic interventionorgan injuryperioperative morbidityperioperative mortalityreceptorrepairedresponsesurgery outcomesystemic inflammatory responsetherapeutic targettissue injurytissue repairtranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Although the mortality of congenital heart disease (CHD) has been reduced significantly, neonates and infants
undergoing cardiac surgery are still at a high risk of morbidity and mortality due to multiple organ injury/failure.
In the Kids’ Inpatient Database, neonates and infants occupied about 57% of all the pediatric population
undergoing congenital heart surgery and carried significantly higher in-hospital mortality rate (6.9%) compared
to other age groups. Delineation of the cause and mechanism of their organ injury/dysfunction would provide
an opportunity to modify our clinical approach and develop therapeutic intervention. Damage-associated
molecular patterns (DAMPs) are endogenous nuclear, mitochondrial, or cytosolic molecules that have
physiological functions inside the cell. However, upon tissue injury, DAMPs are released into the blood stream
by injured cells, and recognized by pattern recognition receptors (PRRs) on neutrophils and platelets. DAMPs
can cause organ injury by inducing systemic inflammatory responses (SIRS) and hypercoagulable state
resulting in thrombosis. The circulating levels of DAMPs correlated to the SIRS and multiple organ injury in
patients with trauma and sepsis. Ischemia-reperfusion injury associated with cardiopulmonary bypass (CPB)
and subsequent organ injury/dysfunction has been well described. In the majority of cardiac surgical cases for
older children and adults, organs other than heart and lung are continuously perfused during CPB, but in
complex neonatal and infant surgery, it is not rare to have surgical repair done under complete circulatory
arrest or regional perfusion only to the brain, suggesting that multiple organs may be subjected to ischemia-
reperfusion injury. Blood transfusion can induce organ injury and is almost always required in neonates and
infants due to their small body size relative to the volume of CPB circuit. Our preliminary study showed that the
circulating levels of DAMPs interacting with Toll-like receptor (TLR)2/4/9 were elevated after CPB separation in
infants and neonates. We hypothesize that 1) in congenital cardiac surgery in neonates and infants, higher
DAMP levels are associated with hypercoagulability (thrombosis) as well as greater organ injury/ dysfunction,
and 2) DAMPs induce more NETs-mediated thrombosis and organ injury in infants via TLRs that in adults. In
Aim 1, we will examine the 1st hypothesis by performing profiling of DAMPs specific to Toll-like receptor
(TLR)2, TLR4 and TLR9 and DAMPs for an aggregate of PRRs, and examine the relationship between DAMPs
and systemic inflammation, neutrophil signature, coagulation, as well as postoperative outcomes of neonates
and infants undergoing surgical repair. In Aim 2, we will test the 2nd hypothesis using human blood in vitro as
well as in vivo mouse model. The goals of this proposal are to 1) establish the correlation between the type
and levels of DAMPs and postoperative organ dysfunction/ outcomes, and 2) to determine responses to
DAMPs including TLR2/4/9 functions in young age. Once we establish the correlation, we will plan to apply an
intervention to reduce DAMP loads or therapeutically target responsible PRRs to mitigate organ injury.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
CD11c as a novel target to improve neutrophil effector functions and sepsis outcome
-
批准号:10552923
-
项目类别:
-
资助金额:$38.94万
-
财政年份:2023
-
负责人:Koichi Yuki
-
依托单位:
The role of damage-associated molecular patterns in perioperative morbidities and mortalities of pediatric congenital heart diseases
-
批准号:10492851
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2022
-
负责人:Koichi Yuki
-
依托单位:
Optimization of anesthetic/sedative regimen for pulmonary pathophysiology in cystic fibrosis patients
-
批准号:10181647
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2021
-
负责人:Koichi Yuki
-
依托单位:
Optimization of anesthetic/sedative regimen for pulmonary pathophysiology in cystic fibrosis patients
-
批准号:10341229
-
项目类别:
-
资助金额:$22.13万
-
财政年份:2021
-
负责人:Koichi Yuki
-
依托单位:
Surgical site infections and the role of anesthesia and bacterial ion transporters
-
批准号:10402288
-
项目类别:
-
资助金额:$33.92万
-
财政年份:2020
-
负责人:Koichi Yuki
-
依托单位:
Surgical site infections and the role of anesthesia and bacterial ion transporters
-
批准号:9883315
-
项目类别:
-
资助金额:$37.17万
-
财政年份:2020
-
负责人:Koichi Yuki
-
依托单位:
The impact of anesthetic selection on sepsis outcome and its mechanism
-
批准号:9452998
-
项目类别:
-
资助金额:$35.4万
-
财政年份:2016
-
负责人:Koichi Yuki
-
依托单位:
The impact of anesthetic selection on sepsis outcome and its mechanism
-
批准号:9250801
-
项目类别:
-
资助金额:$35.4万
-
财政年份:2016
-
负责人:Koichi Yuki
-
依托单位:
The impact of anesthetic selection on sepsis outcome and its mechanism
-
批准号:9072087
-
项目类别:
-
资助金额:$35.4万
-
财政年份:2016
-
负责人:Koichi Yuki
-
依托单位:
Immunomodulatory mechanism of volatile anesthetics
-
批准号:8449579
-
项目类别:
-
资助金额:$19.76万
-
财政年份:2012
-
负责人:Koichi Yuki
-
依托单位:
Immunomodulatory mechanism of volatile anesthetics
-
批准号:8278863
-
项目类别:
-
资助金额:$19.76万
-
财政年份:2012
-
负责人:Koichi Yuki
-
依托单位:
Immunomodulatory mechanism of volatile anesthetics
-
批准号:8636035
-
项目类别:
-
资助金额:$19.76万
-
财政年份:2012
-
负责人:Koichi Yuki
-
依托单位:
Immunomodulatory mechanism of volatile anesthetics
-
批准号:9031116
-
项目类别:
-
资助金额:$15.93万
-
财政年份:2012
-
负责人:Koichi Yuki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: